Asia Pac IPO & Placement Research, China biotech, Aequitas Research

Ke Yan, CFA, FRM

Asia Pac IPO & Placement Research, China biotech

IPOs and Placements coverage across Asia Pacific

Aequitas Research

We cover all listing across the Asia Pacific along with follow-up placements. As of Dec 2020, our team had covered 539 IPOs with a hit rate of 73.5% and 685 placements with a hit rate of 66.8%.

We combine fundamental bottom-up views with our proprietary quantitative framework to provide a holistic coverage across new listings and placements. Our coverage includes pre-IPO notes before the deal is launched, follow-up analysis once the deal is live and post-listing trading analysis as well.

Quantitative Analysis

<ul>
<li>We analyzed the changes in short interest of Bursa stocks as of Oct 10th. The aggregated short interest is USD411m.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Frontken, IHH Healthcare, Bumi Armada, CIMB, SP Setia.</li>
</ul>


We analyzed the changes in short interest of Bursa stocks as of Oct 10th. The aggregated short interest is USD411m.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Frontken, IHH Healthcare, Bumi Armada, CIMB, SP Setia.


Bursa Short Interest Weekly (Oct 10th): Frontken, IHH Healthcare, Bumi Armada, CIMB, SP Setia

Global Healthcare Analyst

Tina Banerjee

Thematic (Sector/Industry)

<ul>
<li>Daiichi Sankyo’s indication expansion application for Enhertu has been accepted for review by FDA for certain types of breast cancers. Santen’s new drug application has been accepted in China.  </li>
<li>Hanmi Pharm entered into a global licensing agreement with Gilead Sciences granting Gilead the exclusive rights to develop and commercialize encequidar. Boryung is acquiring Sanofi’s cytotoxic anti-cancer drug Taxotere.</li>
<li>IHH Healthcare received SEBI approval for mandatory open offer for 26% stake in Fortis Healthcare. Lupin has launched Liraglutide prefilled pen, bioequivalent to Victoza, in the U.S.</li>
</ul>


Daiichi Sankyo’s indication expansion application for Enhertu has been accepted for review by FDA for certain types of breast cancers. Santen’s new drug application has been accepted in China.  
Hanmi Pharm entered into a global licensing agreement with Gilead Sciences granting Gilead the exclusive rights to develop and commercialize encequidar. Boryung is acquiring Sanofi’s cytotoxic anti-cancer drug Taxotere.
IHH Healthcare received SEBI approval for mandatory open offer for 26% stake in Fortis Healthcare. Lupin has launched Liraglutide prefilled pen, bioequivalent to Victoza, in the U.S.


APAC Healthcare Weekly (October 5) – Daiichi Sankyo, Santen, Hanmi Pharm, Boryung, IHH Health, Lupin

<ul>
<li>We analyzed the changes in short interest of Bursa stocks as of Sep 12th. The aggregated short interest is USD365m.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Malaysian Resources, Sime Darby, Bumi Armada, Genting, Yinson.</li>
</ul>


We analyzed the changes in short interest of Bursa stocks as of Sep 12th. The aggregated short interest is USD365m.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Malaysian Resources, Sime Darby, Bumi Armada, Genting, Yinson.


Bursa Short Interest Weekly (Sep 12th): Malaysian Resources, Sime Darby, Bumi Armada, Genting

<ul>
<li>We analyzed the changes in short interest of Bursa stocks as of Sep 5th. The aggregated short interest is USD368m.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Sime Darby, IJM, Telekom Malaysia, Icon Offshore, UEM Sunrise.</li>
</ul>


We analyzed the changes in short interest of Bursa stocks as of Sep 5th. The aggregated short interest is USD368m.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Sime Darby, IJM, Telekom Malaysia, Icon Offshore, UEM Sunrise.


Bursa Short Interest Weekly (Sep 5th): Sime Darby, IJM, Telekom Malaysia, Icon Offshore, UEM Sunrise

<ul>
<li>We analyzed the changes in short interest of Bursa stocks as of Aug 15th. The aggregated short interest is USD421m.</li>
<li>We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.</li>
<li>We highlight short interest changes in Petronas Chemicals, Mr D I Y Group M Bhd, KPJ Healthcare, Tenaga Nasional, Hartalega.</li>
</ul>


We analyzed the changes in short interest of Bursa stocks as of Aug 15th. The aggregated short interest is USD421m.
We tabulate league tables for top short by value and short as multiple of ADT, as well as weekly increases &amp; decreases in short value, short as multiple of ADT.
We highlight short interest changes in Petronas Chemicals, Mr D I Y Group M Bhd, KPJ Healthcare, Tenaga Nasional, Hartalega.


Bursa Short Interest Weekly (Aug 15th): Petronas Chemicals, Mr D I Y Group M Bhd, KPJ Healthcare

Malaysia

Top Glove Corporation Bhd manufactures a wide range of latex gloves.  The Company's products include latex examination powdered, latex examination powderfree, nitrile examination gloves,soft nitrile examination gloves, vinyl examination gloves, surgical gloves, and other related products.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Top Glove Corp (TOPG MK)

Bursa Short Interest Weekly (Oct 10th): Frontken, IHH Healthcare, Bumi Armada, CIMB, SP Setia

We analyzed Bursa Malaysia short interest report for the past week and highlighted short interest changes in Frontken, IHH Healthcare, Bumi Armada,...

Ke Yan, CFA, FRM

APAC Healthcare Weekly (October 5) – Daiichi Sankyo, Santen, Hanmi Pharm, Boryung, IHH Health, Lupin

Daiichi Sankyo’s label expansion application for Enhertu has been accepted by FDA. Hanmi Pharm entered into global licensing agreement with Gilead...

Tina Banerjee

Bursa Short Interest Weekly (Sep 12th): Malaysian Resources, Sime Darby, Bumi Armada, Genting

We analyzed Bursa Malaysia short interest report for the past week and highlighted short interest changes in Malaysian Resources, Sime Darby, Bumi...

Ke Yan, CFA, FRM

Bursa Short Interest Weekly (Sep 5th): Sime Darby, IJM, Telekom Malaysia, Icon Offshore, UEM Sunrise

We analyzed Bursa Malaysia short interest report for the past week and highlighted short interest changes in Sime Darby, IJM, Telekom Malaysia,...

Ke Yan, CFA, FRM

Bursa Short Interest Weekly (Aug 15th): Petronas Chemicals, Mr D I Y Group M Bhd, KPJ Healthcare

We analyzed Bursa Malaysia short interest report for the past week and highlighted short interest changes in Petronas Chemicals, Mr D I Y Group...

Ke Yan, CFA, FRM

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)